Structural intervention patient demographics
| Elective structural (n=42) | |
| Age (year), mean±SD | 80.90±5.92 |
| Male sex, n (%) | 22 (52.4) |
| Black, Asian, minority ethnic, n (%) | 4 (9.5) |
| Height (cm), mean±SD | 165.51±9.90 |
| Weight (kg), mean±SD | 75.02±11.00 |
| Median body surface area (m2) (IQR) | 1.81 (1.71–1.95) |
| Median BMI (IQR) | 26.7 (25.04–31.16) |
| CCS (II–III) | 2 (4.8) |
| NYHA (III–IV) | 30 (71.4) |
| Medical history, n (%) | |
| Hypertension | 22 (52.4) |
| Hypercholesterolaemia | 7 (16.7) |
| Diabetes mellitus | 9 (21.4) |
| IHD (PCI/CABG/MI) | 28 (66.7) |
| Chronic kidney disease | 8 (19.0) |
| Serum creatinine (μmol/L), mean±SD | 109.74±63.89 |
| LV ejection fraction | 53.98±10.45 |
| AVA (cm2) | 0.68±0.18 |
| Peak velocity (ms) | 4.24±0.61 |
| Procedural type, n (%) | |
| TAVI | 39 (92.9) |
| Pulmonary artery intervention | 0 (0) |
| MitraClip | 2 (4.8) |
| Paravalvular leak closure device | 1 (2.4) |
| Complications, n (%) | 8 (18.2) |
| Permanent pacing | 4 (50) |
| Emergency valve surgery | 1 (12.5) |
| Femoral complication | 2 (25) |
| Myocardial infarction | 1 (12.5) |
| Pulmonary oedema | 1 (12.5) |
AVA, aortic valve area; BMI, Body Mass Index; CCS, Canadian Cardiovascular Society; LV, left ventricular; MI, myocardial infarction; NYHA, New York Heart Association; PCI, percutaneous coronary intervention; TAVI, transcatheter aortic valve intervention.